Skip to product information
1 of 1

Phospho-CDK1 (Tyr15) Recombinant Rabbit mAb (S-6330)

Phospho-CDK1 (Tyr15) Recombinant Rabbit mAb (S-6330)

Catalog Number: S0B60745 Application: WB Reactivity: Hu Conjugation: Unconjugated Brand: Starter
Price:
Regular price $100 USD
Regular price Sale price $100 USD
Size:

For shipping services or bulk orders, you may request a quotation.
Secure checkout with
View full details

Product Details

Product Specification


Host Rabbit
Antigen Phospho-CDK1 (Tyr15)
Synonyms Serine/threonine-protein kinase Chk1; CHK1 checkpoint homolog; Cell cycle checkpoint kinase; Checkpoint kinase-1; CHK1; CHEK1
Location Cytoplasm, Cytoskeleton, Nucleus
Accession O14757
Clone Number S-6330
Antibody Type Recombinant mAb
Isotype IgG
Application WB
Reactivity Hu
Purification Protein A
Concentration 0.5 mg/ml
Conjugation Unconjugated
Physical Appearance Liquid
Storage Buffer

PBS, 40% Glycerol, 0.05% BSA, 0.02% sodium azide

Stability & Storage

12 months from date of receipt / reconstitution, -20 °C as supplied

Dilution


application dilution species
WB 1:1000-1:2000 Hu

Background

Phospho-CDK1 (Tyr15) refers to the inactive form of cyclin-dependent kinase 1 (CDK1) generated upon phosphorylation at the Tyr15 residue, and represents a core molecular event in G2/M checkpoint regulation. Once CDK1 binds Cyclin B, it is poised to drive cells into mitosis, but phosphorylation of Tyr15 by Wee1 kinase inhibits its kinase activity, causing cells to arrest in G2 phase to allow completion of DNA repair or to cope with replication stress. When cells are ready to divide, the Cdc25 phosphatase removes the phosphate group at Tyr15, and CDK1 becomes activated and triggers mitotic entry. In experimental detection, the phosphorylation level at Tyr15 is commonly used as a marker of CDK1 inactivation and G2/M arrest: low levels of phospho-CDK1 (Tyr15) indicate that CDK1 is activated and cells are entering mitosis, whereas elevated phosphorylation at this site reflects checkpoint activation or suppression of CDK1 activity. In clinically relevant studies, combined detection of phospho-CDK1 (Tyr15) and dephosphorylated CDK1 has been used to assess prognosis in non-small cell lung cancer, with both showing prognostic significance.

Picture

Western Blot

WB result of Phospho-CDK1 (Tyr15) Recombinant Rabbit mAb Primary antibody: Phospho-CDK1 (Tyr15) Recombinant Rabbit mAb at 1/1000 dilution
Blocking/Diluting buffer and concentration: 5% NFDM/TBST
Lane 1: untreated HeLa whole cell lysate 20 µg
Lane 2: HeLa treated with 4mM Hydroxyurea for 20 hours whole cell lysate 20 µg
Secondary antibody: Goat Anti-Rabbit IgG (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 54 kDa
Observed MW: 31 kDa